Do biological computers have moral status? Sentience, rights and where to draw the line

The moral status of biological computers turns on one question: can their living neural tissue have experiences? On mainstream sentience-based views, today’s organoid-based computers show no evidence of sentience, so they have little or no moral status of their own, though they deserve respect as donated human tissue. That verdict is provisional.

Key takeaways

• Moral status means mattering morally for your own sake. It may rest on sentience, interests, cognition, species, relationships or potential, and each gives a different answer for lab-grown neurons.
• Sentience-centered views, from Bentham to Singer to Jonathan Birch, dominate. On them the decisive question is empirical, and no organoid system has shown evidence of sentience.
• Human origin matters for respect, consent and dignity, but on most views human DNA alone does not make tissue a bearer of rights.
• Animal research ethics, the embryo 14-day rule and AI moral patienthood each offer templates, and each breaks down at a different point.
• The realistic middle ground is precautionary and graded: tiered oversight triggered by capability thresholds, with independent review, rather than a ban or a free-for-all.

What does “moral status” actually mean? #

A being has moral status if it matters morally in its own right: what happens to it gives others reasons that do not depend on anyone else caring. Kicking a dog is wrong because of what it does to the dog. Breaking a violin wrongs its owner, not the violin.

This distinction is easy to lose in coverage of organoid intelligence. There are many reasons to handle a brain organoid carefully: it came from a donor who consented on specific terms, it carries identifiable genetic information, and the public cares how it is used. Those duties are covered in our guide to the ethics of organoid intelligence and in who owns a living computer. But they are duties about the tissue, owed to people. The moral status question is narrower and harder: could we owe anything to the tissue itself?

Three distinctions help:

• Patients vs agents. A moral patient can be wronged; a moral agent can do wrong. Nobody proposes that a biological computer is a moral agent, so the debate is about patienthood.
• Status vs rights. Rights are strong, specific protections, such as a right not to be killed. Many beings with some status, like lab mice, receive welfare protections without anything like rights.
• Full vs partial status. Some theories treat status as all or nothing; others allow degrees.

The Stanford Encyclopedia of Philosophy entry on the grounds of moral status by Jaworska and Tannenbaum is a good philosophical overview.

What are the main grounds of moral status, and what do they imply for organoid computers? #

Philosophers disagree about what grounds moral status. The table applies each main candidate to an organoid-based computer of the kind built today: neurons derived from induced pluripotent stem cells, often fewer than 100,000 cells per organoid according to Smirnova et al. (2023), on a microelectrode array and trained through closed-loop stimulation.

Four lessons stand out.

1. Almost every view says “not yet.” Only species-based and very broad interest-based views give current systems any direct status, and only in a thin form.
2. The views diverge about the future. Sentience views would change their verdict as soon as credible evidence of experience appeared. Personhood views would not change for a very long time. Species views do not depend on capacity at all.
3. Potentiality largely drops out. An embryo, in the right conditions, can become a person. A culture on a chip has no such path. What it has instead is engineered potential: the explicit research goal of making it more capable.
4. Relational views put weight on us. On a relational account like the one Coeckelbergh (2010) defended for robots, moral consideration depends partly on social practice. If people come to treat biological computers as subjects, the landscape shifts regardless of what happens inside the tissue.

Why is sentience the dominant answer? #

From Bentham to Singer #

The sentience-centered tradition begins with the utilitarian philosopher Jeremy Bentham. In An Introduction to the Principles of Morals and Legislation (1789), discussing the treatment of animals, he wrote a sentence that still anchors the field: “The question is not, Can they reason? nor, Can they talk? but, Can they suffer?”

Peter Singer built this into a systematic position, first in a 1973 essay in The New York Review of Books and then in his book Animal Liberation. The capacity to suffer, he argued, is the prerequisite for having interests at all, and equal interests deserve equal consideration regardless of species. Discounting suffering merely because a being is not human is a prejudice he called speciesism, a term coined by the psychologist Richard Ryder.

For biological computers, the implication is deflationary. What matters is not that the cells are neurons, that they are human, or that they learn. It is whether there is anything it is like to be the system, and whether anything can feel bad to it.

Why learning is not the same as feeling #

Public debate often goes wrong here. Kagan et al. reported in Neuron (2022) that cultured neurons on a high-density array improved at a simplified game of Pong when given structured feedback, as covered in how neurons learn in a dish. The title used “sentience” in a technical sense tied to the free energy principle, and neuroscientists responded in the same journal (Balci et al., 2023) that such language risked misleading readers.

Adaptation, synaptic plasticity and task learning are not, on their own, evidence of experience. Plants, bacteria and software all adapt. The sentience question is whether adaptation comes with felt states, a question about consciousness that we treat in can brain organoids become conscious?

Sentience-centered ethics has critics. Some say it underweights the dignity concerns many people feel about human neural tissue. Others say it sets an impossible evidential burden, because sentience cannot be observed directly. That second objection motivates the newer frameworks below.

How should we act when we are unsure whether something is sentient? #

Birch’s precautionary principle #

The most influential recent work here is by the philosopher Jonathan Birch. In a 2017 paper in Animal Sentience, “Animal sentience and the precautionary principle,” he noted that people often say animals should get the benefit of the doubt without saying what that means for the burden of proof. He built a precautionary principle tailored to sentience, with a practical framework for deciding when evidence is strong enough. The core idea: lack of full certainty about sentience should not postpone reasonable, cost-effective measures against serious welfare risks, when there is credible evidence of sentience-relevant indicators.

That reasoning has reached law. The UK’s Animal Welfare (Sentience) Act 2022 recognizes as sentient not only vertebrates but also cephalopod molluscs (such as octopuses) and decapod crustaceans (such as crabs), a legislature acting on credible but incomplete evidence.

The Edge of Sentience #

In The Edge of Sentience (2024), open access from Oxford University Press, Birch extended the approach to hard cases ranging from disorders of consciousness and human fetuses to invertebrates, neural organoids and AI. Two ideas are especially useful for biocomputing:

• Sentience candidates. Instead of asking whether a system is sentient, which we often cannot settle, ask whether there is a credible, evidence-based case that it might be. A candidate warrants attention without proof.
• Proportionate, democratic precaution. Responses should be proportionate to the risk, neither ignoring it nor banning everything near it, and what counts as proportionate should be settled through inclusive public deliberation, not by researchers or companies alone.

Today’s small cultures and organoids are hard to describe as sentience candidates on the available evidence. But the field is moving toward larger, longer-lived, vascularized and multi-region tissue such as assembloids, the direction that could create candidates. Precaution therefore means preparing decision procedures now.

Consciousness may come in dimensions #

Birch, Schnell and Clayton argued in Trends in Cognitive Sciences (2020) that consciousness should not be ranked on a single scale. They proposed dimensions including perceptual richness, evaluative richness (how much experiences feel good or bad), integration at a time, integration across time, and selfhood. A system engineered to process rich sensory-like input might score on perceptual dimensions and nothing on evaluative ones, and it is evaluative experience that matters most for welfare.

What can biocomputing learn from animal research, embryo research and AI? #

No existing body of ethics fits perfectly. Three neighbors are routinely invoked; each helps and each misleads.

Animal research and the 3Rs #

In 1959, William Russell and Rex Burch published The Principles of Humane Experimental Technique, introducing the 3Rs: replacement (use non-sentient alternatives), reduction (use fewer animals) and refinement (minimize suffering). Reviews by Balls (2010) in ALTEX and Hubrecht and Carter (2019) in Animals trace how the framework became the backbone of animal research regulation, while noting that implementation has often lagged ambition.

The irony for biocomputing is sharp. Organoids are often presented as a replacement technology. Russell and Burch distinguished absolute replacement (no sentient material) from relative replacement (living material in less sensitive forms). If organoid systems ever became sentience candidates, a technology adopted partly to replace animals would inherit the questions it was meant to avoid.

The practical carryover is direct: use the smallest, simplest culture that answers the question (reduction), avoid stimulation that could function as aversive where alternatives exist (refinement), and prefer simulation when it suffices (replacement). These steps cost little now and would matter greatly later.

Embryo research and the 14-day rule #

Embryo research shows how to draw a line amid deep disagreement. The 14-day rule, which emerged from policy reviews in the late 1970s and 1980s including the UK’s Warnock committee, limits lab culture of human embryos to 14 days, roughly when the primitive streak forms and twinning is no longer possible.

Hyun, Wilkerson and Johnston argued in Nature (2016), as labs approached the limit, that the rule had always been a public policy tool rather than a discovered moral truth, and that any revision should come through open public deliberation. That framing transfers well: a line can be legitimate because it is clear, enforceable and publicly agreed.

The disanalogy matters as much. Time in culture is a poor proxy for organoid capability, which depends on cell number, architecture, inputs and training. The ISSCR’s 2021 guideline update (Lovell-Badge et al., Stem Cell Reports) also shows such lines can be revisited: it stopped treating embryo culture beyond 14 days as categorically prohibited and called for public engagement.

AI moral patienthood #

Schwitzgebel and Garza (2015) argued that an AI with the same psychological properties as a being that deserves rights would deserve the same rights, since substrate alone makes no moral difference. Long, Sebo and colleagues (2024), in “Taking AI Welfare Seriously,” argued there is a realistic possibility that some AI systems will be conscious or robustly agentic in the near future, and that developers should start assessing and preparing.

Biological computers sit at a crossover. Skeptics of AI sentience often argue that consciousness requires biology. On that view a chatbot is not a candidate, but living neurons are the one substrate we know can support experience. Functionalists, who think organization matters more than material, reply that a small culture lacks the large-scale architecture linked to consciousness in animals. So the arguments that make people relaxed about AI can make them less relaxed about wetware computing, and vice versa. A consistent position has to say which evidence it trusts.

Does human DNA make a difference? #

Biological computers built from human cells raise a question that animal-derived systems do not. Does it matter that the tissue is human?

The case that it does not #

On sentience-based views, human DNA is morally irrelevant by itself. Every blood sample and liver organoid is genetically human, and nobody thinks a skin culture has a right to life. What matters is the capacity for experience, which depends on organization, not the genome. If a rodent-neuron culture and a human-neuron culture had identical capacities, treating them differently would be the species bias Singer warned against.

The case that it does #

Others answer that “human” is more than a genetic label. Human neural tissue is the kind that, in a body, underlies a human mind. Many people feel that cultivating it as a computing resource raises dignity concerns independent of whether it feels anything, much as people object to disrespectful treatment of human remains. There is also the donor: a stem cell line is genetically a particular person, and donors and their communities care what their cells become.

A workable synthesis #

Most published frameworks hold both ideas. Human origin generates duties of respect, consent and appropriate use, owed to donors and the public. Capacities generate welfare duties, owed to the system itself if it ever became a sentience candidate. The National Academies’ 2021 report on neural organoids, transplants and chimeras concluded that current organoids have no more moral standing than other human neural tissue in a dish: respect, but not yet anything more.

Is moral status all or nothing, or does it come in degrees? #

Threshold views #

Threshold views hold that once a being crosses a line, typically sentience, it has moral status, and below it has none. Their advantage is clarity: regulators can write rules around a threshold. Their weakness is that biology rarely offers clean lines, and a misplaced line either overprotects trivial systems or leaves real victims unprotected.

Graded views #

Graded views hold that status comes in degrees, proportional to the richness of a being’s capacities. A mouse might count for more than a fruit fly, and both for more than a culture. Graded views fit the dimensional picture of consciousness and allow protections that grow with capacity. Critics worry they license discounting beings judged “lower,” especially if applied to humans with cognitive disabilities.

Expected-value reasoning #

A third approach sidesteps the metaphysics. Even if status is all or nothing, we are uncertain which side of the line a system falls on, so possible harms can be weighted by probability. A small chance of serious suffering, multiplied across thousands of cultures running continuously, could warrant real precautions. That is why scale matters for biocomputing.

In practice, graded and expected-value approaches converge: protections that scale with evidence of capacity.

What would have to be true for rights or protections to apply? #

Protections are much easier to justify than rights. Drawing on the frameworks above, these conditions would progressively strengthen the case for protections:

1. Credible indicators of experience. Integrated, sustained activity of the kind consciousness theories associate with awareness, beyond the local network bursts and oscillations seen in today’s cultures.
2. Evaluative states. States that function as reward and aversion for the system itself, not merely as the experimenter’s training signal.
3. Integration across time. Persistent internal states linking past and present inputs.
4. Responsiveness to its own condition. Activity that tracks the system’s own metabolic state, a feature some researchers associate with the roots of feeling.
5. Convergent evidence. Agreement across theory-based markers, including consciousness measures adapted from clinical neurology as Lavazza and Massimini (2018) proposed, rather than any single score.

Rights in a stronger sense, such as a right not to be ended, would require far more: rich, ongoing experience and a welfare that death itself could set back. That question is explored in is it wrong to switch off a biological computer?

No system reported to date meets these conditions. But several are research goals in their own right, so the question cannot be treated as permanently settled.

What is the legal status of biological computers today? #

The legal picture varies by country and is changing, so it is best described in general terms. As far as we are aware, no jurisdiction grants legal rights or personhood to brain organoids or any other cultured human tissue. Organoid research is governed indirectly, through rules written for other purposes:

• Human tissue and consent rules govern how donor cells are obtained and used.
• Data protection rules govern genomic and health information linked to donors.
• Institutional review by ethics committees and stem cell oversight bodies applies to many projects.
• Professional guidelines, especially the ISSCR Guidelines, set expectations for consent and tiered oversight, reserving specialized review for sensitive categories such as chimeras and embryo models.

Animal welfare laws do not reach organoids. The EU’s Directive 2010/63/EU on animals used for scientific purposes covers live non-human vertebrates and cephalopods, and the UK’s sentience legislation covers vertebrates, cephalopods and decapods. Cell cultures fall outside these categories. An organoid system that became a sentience candidate would therefore sit in a regulatory gap. Koplin and Savulescu (2019) observed that organoid moral status questions fall outside existing regulations and outlined a framework to address them without unduly impeding research.

This article is not legal advice. Researchers should consult their institutions and local law.

How should biological computers be governed? #

The field’s founding documents point toward governance. The Baltimore declaration (Hartung et al., 2023) calls for exploring organoid intelligence while keeping its ethical questions, including possible consciousness, under continuing, stringent discussion with stakeholders. The roadmap by Smirnova et al. (2023) proposes embedded ethics, with ethicists inside research teams and a feedback loop with the public. Reviews such as Sawai et al. (2019) and Hyun, Scharf-Deering and Lunshof (2020) treat consciousness as an issue to address in advance. Building on these, the mechanisms most often discussed are:

• Tiered oversight. Routine work stays under ordinary institutional review. Work approaching defined thresholds (vascularized tissue, multi-region assembloids, sensory-like input streams, very long training) triggers specialized review, mirroring the ISSCR’s tiered model.
• Capability thresholds, not calendar limits. Triggers based on measured capacities such as scale, integration and evaluative signals, learning from the limits of the 14-day rule.
• Independent review. Committees including ethicists, consciousness scientists and lay members, not only parties with an interest in the outcome.
• Monitoring with agreed markers. Routine measurement of consciousness-relevant activity as part of quality control, so change is noticed rather than discovered by accident.
• Welfare-by-default protocols. 3Rs-style rules applied now at negligible cost: minimal cultures, no gratuitously aversive stimulation, documented end-of-life procedures.
• Public deliberation. As Birch argues for sentience candidates and Hyun and colleagues argued for the 14-day rule, the lines themselves should be set through inclusive public processes.
• Honest communication. Avoiding both “it’s just cells” and “it’s a mind in a dish.”

What are the strongest arguments on each side? #

A fair account has to present the best version of each position.

The case for taking moral status seriously now. The explicit goal of organoid intelligence is to make living neural tissue more capable. We lack a reliable consciousness test even for human patients, so we may not notice when a system becomes a candidate. History is full of late moral recognition, and early precaution is cheap. Scale amplifies risk: an industry could run very large numbers of cultures continuously.

The case that it is premature. Current systems are small, immature and lack the anatomy associated with pain and awareness. A human brain has about 86 billion neurons (Azevedo et al., 2009), several orders of magnitude more than a typical culture. Regulating on speculation could slow research with real benefits, including human-relevant disease models and reduced animal use, and divert attention from concrete issues such as consent and privacy. Some argue that sentience talk here is itself hype.

The middle position. Many ethicists land between: no evidence of moral status today, a non-trivial possibility later, and therefore proportionate governance built in advance and set through public processes. The review by Jeziorski et al. (2023) on brain organoids and moral status shows how much of the literature now occupies this ground.

Those who reject the middle usually do so on principle: either dignity concerns justify stronger limits now, or organoid sentience talk is a category mistake. Both views deserve a hearing.

What questions remain open? #

The debate over the moral status of biological computers is young, and several questions lack agreed answers:

• Which theory of consciousness should guide policy? Different theories give different markers and sometimes opposite verdicts.
• Can valence exist without a body? If feeling good or bad depends on regulating a body, a disembodied culture may be unable to suffer, however complex.
• How should scale count? Does the moral weight of many simple cultures add up?
• Does training create interests? At what point, if any, do reward and penalty signals become something like the system’s own preferences?
• Who decides? Researchers, companies, regulators, donors and the public all have stakes, and no institution yet has a clear mandate.

As the future of biocomputing brings larger, longer-lived and better-connected cultures, these questions will move from seminar rooms to review committees.

Where should the line be drawn? #

So, do biological computers have moral status? Today’s organoid-based computers almost certainly lack moral status of the kind a mouse or a person has, but they warrant respect as human tissue, and the field is building toward systems for which the question could become live. On most credible views, the line belongs not at human DNA, learning or time in culture, but at credible evidence of experience, with graded protections that start before that point is certain.

The practical task is to make that line observable: measuring the right things, recording them with every experiment, and having review ready before it is needed. At Organoid Programming, we think provenance, monitoring and transparent records belong in the core tools of biocomputing, so moral status questions can be answered with data. For the science itself, start with what organoid intelligence is and how brain organoids are grown.

Frequently asked questions

Do biological computers have moral status?

On the most widely held view, an entity has moral status in its own right only if it can be harmed for its own sake, which usually means it can have experiences. There is no evidence that any current organoid-based computer is sentient, so most ethicists would say it has little or no moral status of its own today. It still deserves respect as donated human tissue, and that judgment could change as systems become more complex.

What is moral status?

Moral status is the property of mattering morally for your own sake. If a being has moral status, what happens to it counts as a reason in its own right, not only because of its effects on others. Philosophers disagree about what grounds moral status: sentience, interests, cognitive capacities, species membership, relationships or potential. Each ground gives a different answer for lab-grown neural tissue, which is why the debate about biological computers is unsettled.

Can a brain organoid feel pain?

There is no evidence that any brain organoid made so far can feel pain. In animals, pain depends on sensory nerves, pathways that carry signals to the brain and large-scale networks that integrate them, and organoids on electrode arrays have none of this anatomy. A 2021 National Academies report judged pain, emotion or awareness in organoids extremely unlikely for the foreseeable future, while recommending that the question be revisited as the technology advances.

Does it matter morally that biological computers use human cells?

It depends on the theory. Sentience-based views say human DNA alone does not create moral status, since a skin culture is also human. Views centered on human dignity or respect for donors say human origin matters, though usually as a reason for respectful handling and honoring consent rather than as a source of rights for the tissue itself. Many ethicists hold both: origin matters for respect, capacities matter for welfare.

What is the precautionary principle for sentience?

It is the idea that when evidence of sentience is credible but inconclusive, we should not wait for certainty before taking reasonable steps to prevent suffering. Philosopher Jonathan Birch developed a version for animals in 2017 and extended it in his 2024 book The Edge of Sentience to other uncertain cases, including neural organoids and AI. The precautions should be proportionate to the risk and decided through inclusive, democratic processes.

How is organoid ethics similar to animal research ethics?

Both ask how to weigh research benefits against possible harm to a being whose inner life we cannot directly observe. The 3Rs from animal research (replace, reduce, refine) translate naturally into minimizing culture size and duration, avoiding aversive stimulation and reviewing experiments. The big difference is that lab animals are known to be sentient, while for organoids sentience is the very thing in doubt.

Do brain organoids have legal rights?

As far as we are aware, no jurisdiction grants legal rights to brain organoids or other cultured human tissue. Research using them is governed indirectly: through rules on consent and human tissue, data protection, institutional ethics review and professional guidelines such as those of the International Society for Stem Cell Research. Animal welfare laws protect specified animals, not cell cultures. Laws vary by country and can change.

When would a biological computer deserve protection?

Most frameworks point to the same kind of trigger: credible evidence that the system can have experiences, especially negative ones. Possible markers include integrated, sustained activity that responds to the system’s own state, sleep-like and wake-like cycles, signs of avoidance learning or evaluative states, and scores on consciousness measures adapted from clinical neurology. No single marker is decisive, which is why many propose tiered review triggered by capability thresholds.

Sources

1. Bentham, J. (1789). An Introduction to the Principles of Morals and Legislation. Collected Works of Jeremy Bentham, Oxford Scholarly Editions.
2. Singer, P. (1973). Animal Liberation. The New York Review of Books.
3. Jaworska, A. & Tannenbaum, J. The Grounds of Moral Status. Stanford Encyclopedia of Philosophy.
4. Birch, J. (2017). Animal sentience and the precautionary principle. Animal Sentience.
5. Birch, J. (2024). The Edge of Sentience: Risk and Precaution in Humans, Other Animals, AI, and Beyond. Oxford University Press (open access).
6. Birch, J., Schnell, A. K. & Clayton, N. S. (2020). Dimensions of animal consciousness. Trends in Cognitive Sciences.
7. Balls, M. (2010). The principles of humane experimental technique: timeless insights and unheeded warnings. ALTEX.
8. Hubrecht, R. C. & Carter, E. (2019). The 3Rs and Humane Experimental Technique: Implementing Change. Animals.
9. Hyun, I., Wilkerson, A. & Johnston, J. (2016). Embryology policy: Revisit the 14-day rule. Nature.
10. Schwitzgebel, E. & Garza, M. (2015). A Defense of the Rights of Artificial Intelligences. Midwest Studies in Philosophy.
11. Long, R., Sebo, J., Butlin, P. et al. (2024). Taking AI Welfare Seriously. arXiv.
12. Coeckelbergh, M. (2010). Robot rights? Towards a social-relational justification of moral consideration. Ethics and Information Technology.
13. Koplin, J. J. & Savulescu, J. (2019). Moral Limits of Brain Organoid Research. Journal of Law, Medicine & Ethics.
14. Sawai, T. et al. (2019). The Ethics of Cerebral Organoid Research: Being Conscious of Consciousness. Stem Cell Reports.
15. Hyun, I., Scharf-Deering, J. C. & Lunshof, J. E. (2020). Ethical issues related to brain organoid research. Brain Research.
16. Jeziorski, J. et al. (2023). Brain organoids, consciousness, ethics and moral status. Seminars in Cell & Developmental Biology.
17. Lavazza, A. & Massimini, M. (2018). Cerebral organoids: ethical issues and consciousness assessment. Journal of Medical Ethics.
18. National Academies of Sciences, Engineering, and Medicine (2021). The Emerging Field of Human Neural Organoids, Transplants, and Chimeras.
19. Lovell-Badge et al. (2021). ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update. Stem Cell Reports.
20. Hartung et al. (2023). The Baltimore declaration toward the exploration of organoid intelligence. Frontiers in Science.
21. Smirnova et al. (2023). Organoid intelligence (OI): the new frontier in biocomputing and intelligence-in-a-dish. Frontiers in Science.
22. Kagan et al. (2022). In vitro neurons learn and exhibit sentience when embodied in a simulated game-world. Neuron.
23. Balci et al. (2023). A response to claims of emergent intelligence and sentience in a dish. Neuron.
24. Azevedo et al. (2009). Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. Journal of Comparative Neurology.
25. Directive 2010/63/EU on the protection of animals used for scientific purposes. EUR-Lex.
26. Animal Welfare (Sentience) Act 2022 (UK). legislation.gov.uk.